PATIENT INFO: CLINICAL TRIALS
Search Clinical Trials Parent Therapeutic Areas: Oncology
Lymphocytic Leukemia, Chronic
State
Country
Alabama
Birmingham : Research Site:
A Study to Evaluate MabThera (Rituximab) in Patients Previously Treated for Chronic Lymphocytic Leukemia
California
Fountain Valley : Research Site:
Fresno : Research Site:
Illinois
Chicago : Research Site:
Kentucky
Lexington : University of Kentucky Chandler Medical Center
Cancer: Chronic Lymphocytic Leukemia (CLL) Research Study
Maryland
Baltimore : National Institute on Aging
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
New York
New Hyde Park : Biomedical Research Alliance of New York
B-CLL CHRONIC LYMPHOCYTIC LEUKEMIA - Adults
North Carolina
Durham : Research Site:
Pennsylvania
Hershey : Research Site:
Argentina
Buenos Aires : Research Site:
A Study of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia (CLL)
A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Córdoba : Research Site:
La Plata : Research Site:
Pilar : Research Site:
Rosario : Research Site:
Australia
Adelaide : Research Site:
Brisbane : Research Site:
A Study of MabThera (Rituximab) in Combination With a Chemotherapy Regimen for the Treatment of Chronic Lymphocytic Leukemia.
Frankston : Research Site:
Fremantle : Research Site:
Geelong : Research Site:
Gosford : Research Site:
Greenslopes : Research Site:
Kogarah : Research Site:
Melbourne : Research Site:
Newcastle : Research Site:
Perth : Research Site:
St. Leonards : Research Site:
Sydney : Research Site:
Woolloongabba : Research Site:
Austria
Graz : Research Site:
Innsbruck : Research Site:
CHAIROS study A Study of MabThera (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
Leoben : Research Site:
Linz : Research Site:
Salzburg : Research Site:
A Proof of Concept Study of the Safety, Tolerability and Efficacy of Avastin (Bevacizumab) in Patients With Chemonaive Chronic Lymphocytic Leukemia (CLL)
Wels : Research Site:
Wien : Research Site:
Belgium
Antwerpen : Research Site:
Brugge : Research Site:
Bruxelles : Research Site:
Edegem : Research Site:
Leuven : Research Site:
Mont-Godinne : Research Site:
Brazil
Belo Horizonte : Research Site:
Goiania : Research Site:
Porto Alegre : Research Site:
Santo Andre : Research Site:
Sao Paulo : Research Site:
Bulgaria
Plovdiv : Research Site:
Sofia : Research Site:
Varna : Research Site:
Canada
Barrie, ON : Research Site:
Burnaby, BC : Research Site:
Calgary, AB : Research Site:
Edmonton, AB : Research Site:
Halifax, NS : Research Site:
Hamilton, ON : Research Site:
Montreal, QC : Research Site:
Ottawa, ON : Research Site:
Saskatoon, SK : Research Site:
Toronto, ON : Research Site:
Vancouver, BC : Research Site:
Winnipeg, MB : Research Site:
China
Hong Kong : Research Site:
Croatia
Zagreb : Research Site:
Czech Republic
Brno : Research Site:
Hradec Kralove : Research Site:
Olomouc : Research Site:
Plzen : Research Site:
Praha : Research Site:
Praha 2 : Research Site:
Denmark
Aalborg : Research Site:
Århus : Research Site:
Herlev : Research Site:
København : Research Site:
Vejle : Research Site:
Estonia
Tallinn : Research Site:
Tartu : Research Site:
France
Angers : Research Site:
Bobigny : Research Site:
Bordeaux : Research Site:
Caen : Research Site:
Clermont-Ferrand : Research Site:
Colmar : Research Site:
Creteil : Research Site:
Le Chesnay : Research Site:
Le Mans : Research Site:
Lille : Research Site:
Limoges : Research Site:
Lyon : Research Site:
Marseille : Research Site:
Montpellier : Research Site:
Nantes : Research Site:
Paris : Research Site:
Pessac : Research Site:
Pierre Benite : Research Site:
Poitiers : Research Site:
Quimper : Research Site:
Reims : Research Site:
Rennes : Research Site:
Rouen : Research Site:
Saint-Priest-En-Jarez : Research Site:
Strasbourg : Research Site:
Toulouse : Research Site:
Tours : Research Site:
Vandoeuvre-Les-Nancy : Research Site:
Germany
Ahaus : Research Site:
Amberg : Research Site:
Ansbach : Research Site:
Augsburg : Research Site:
Bad Saarow : Research Site:
Bayreuth : Research Site:
Berlin : Research Site:
Bielefeld : Research Site:
Bietigheim-Bissingen : Research Site:
Bochum : Research Site:
Bottrop : Research Site:
Bremen : Research Site:
Burglengenfeld : Research Site:
Coesfeld : Research Site:
Cottbus : Research Site:
Delitzsch : Research Site:
Detmold : Research Site:
Dresden : Research Site:
Düsseldorf : Research Site:
Eisenach : Research Site:
Erfurt : Research Site:
A Study of MabThera (Rituximab) in Combination Chemotherapy in Patients With B-Cell Chronic Lymphocytic Leukemia
Erlangen : Research Site:
Eschweiler : Research Site:
Essen : Research Site:
Esslingen : Research Site:
Forchheim : Research Site:
Frankfurt Am Main : Research Site:
Frankfurt An Der Oder : Research Site:
Freiburg : Research Site:
Garmisch-Partenkirchen : Research Site:
Gerlingen : Research Site:
Giessen : Research Site:
Göttingen : Research Site:
Greifswald : Research Site:
Grenzach-Wyhlen : Research Site:
Hagen : Research Site:
Halle : Research Site:
Hamburg : Research Site:
Hamm : Research Site:
Hannover : Research Site:
Heidelberg : Research Site:
Herne : Research Site:
Herrsching : Research Site:
Homburg : Research Site:
Idar-Oberstein : Research Site:
Jena : Research Site:
Karlsruhe : Research Site:
Kassel : Research Site:
Kempten : Research Site:
Kiel : Research Site:
Koblenz : Research Site:
Köln : Research Site:
Kronach : Research Site:
Landshut : Research Site:
Lebach : Research Site:
Leer : Research Site:
Leipzig : Research Site:
Lemgo : Research Site:
Lörrach : Research Site:
Lübeck : Research Site:
Lüdenscheid : Research Site:
Ludwigshafen : Research Site:
Magdeburg : Research Site:
Mainz : Research Site:
Mannheim : Research Site:
München : Research Site:
Münchengladbach : Research Site:
Münster : Research Site:
Mutlangen : Research Site:
Neunkirchen : Research Site:
Nordenstedt : Research Site:
Nürnberg : Research Site:
Oberhausen : Research Site:
Offenbach : Research Site:
Oldenburg : Research Site:
Pasewalk : Research Site:
Pforzheim : Research Site:
Potsdam : Research Site:
Recklinghausen : Research Site:
Regensburg : Research Site:
Rostock : Research Site:
Rüsselsheim : Research Site:
Saarbrücken : Research Site:
Sande : Research Site:
Siegen : Research Site:
Stuttgart : Research Site:
Torgau : Research Site:
Trier : Research Site:
Troisdorf : Research Site:
Tübingen : Research Site:
Twistringen : Research Site:
Ulm : Research Site:
Villingen-Schwenningen : Research Site:
Wanzleben : Research Site:
Weiden : Research Site:
Weilheim : Research Site:
Wesel : Research Site:
Wiesbaden : Research Site:
Witten : Research Site:
Worms : Research Site:
Wuppertal : Research Site:
Würzburg : Research Site:
Hong Kong
Hungary
Budapest : Research Site:
Debrecen : Research Site:
Pecs : Research Site:
Szeged : Research Site:
Israel
Beer Sheva : Research Site:
Haifa : Research Site:
Jerusalem : Research Site:
Kfar Saba : Research Site:
Naharia : Research Site:
Petach Tikva : Research Site:
Ramat Gan : Research Site:
Rehovot : Research Site:
Italy
Bari : Research Site:
A Study of MabThera (Rituximab) plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.
Bologna : Research Site:
Cagliari : Research Site:
Catania : Research Site:
Catanzaro : Research Site:
Cosenza : Research Site:
Ferrara : Research Site:
Firenze : Research Site:
Genova : Research Site:
Messina : Research Site:
Milano : Research Site:
Napoli : Research Site:
Padova : Research Site:
Pavia : Research Site:
Reggio Calabria : Research Site:
Roma : Research Site:
A Study of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia (CLL) Responsive to First Line Therapy
San Giovanni Rotondo : Research Site:
Siena : Research Site:
Torino : Research Site:
Verona : Research Site:
Vicenza : Research Site:
Mexico
Aguascalientes : Research Site:
Culiacan : Research Site:
Mexico City : Research Site:
Monterrey : Research Site:
San Luis Potosi : Research Site:
Netherlands
Amersfoort : Research Site:
Amsterdam : Research Site:
Den Haag : Research Site:
Enschede : Research Site:
Nieuwegein : Research Site:
Rotterdam : Research Site:
New Zealand
Auckland : Research Site:
Christchurch : Research Site:
Palmerston North : Research Site:
Wellington : Research Site:
Norway
Bergen : Research Site:
Oslo : Research Site:
Poland
Bialystok : Research Site:
A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-cell Chronic Lymphocytic Leukemia
Katowice : Research Site:
Krakow : Research Site:
Lodz : Research Site:
Lublin : Research Site:
Poznan : Research Site:
Warszawa : Research Site:
Wroclaw : Research Site:
Romania
Bucharest : Research Site:
Targu-Mures : Research Site:
Russian Federation
Kazan : Research Site:
Moscow : Research Site:
Nizhny Novgorod : Research Site:
Obninsk : Research Site:
Penza : Research Site:
Perm : Research Site:
Rostov-Na-Donu : Research Site:
Samara : Research Site:
St Petersburg : Research Site:
Ufa : Research Site:
Slovakia
Bratislava : Research Site:
Spain
Alcala De Henares : Research Site:
A Study of MabThera (Rituximab) in First Line Treatment of Chronic Lymphocytic Leukemia.
Alcorcon : Research Site:
Badajoz : Research Site:
Barcelona : Research Site:
Barranco De La Ballena, S/N : Research Site:
Bilbao : Research Site:
Caceres : Research Site:
Cádiz : Research Site:
Castellon : Research Site:
Gandia : Research Site:
Granada : Research Site:
Hospitalet de Llobregat : Research Site:
Jaen : Research Site:
Jerez De La Frontera : Research Site:
La Coruna : Research Site:
La Laguna : Research Site:
Madrid : Research Site:
Malaga : Research Site:
Manresa : Research Site:
Mostoles : Research Site:
Murcia : Research Site:
Oviedo : Research Site:
Pamplona : Research Site:
Sabadell : Research Site:
Sagunto : Research Site:
Salamanca : Research Site:
San Sebastian : Research Site:
Santander : Research Site:
Santiago de Compostela : Research Site:
Sevilla : Research Site:
Toledo : Research Site:
Valencia : Research Site:
Vitoria : Research Site:
Zaragoza : Research Site:
Sweden
Huddinge : Research Site:
Linkoeping : Research Site:
Switzerland
Aarau : Research Site:
Basel : Research Site:
Bern : Research Site:
Chur : Research Site:
Luzern : Research Site:
St. Gallen : Research Site:
Zürich : Research Site:
Thailand
Bangkok : Research Site:
Khon Kaen : Research Site:
United Kingdom
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia.
Bournemouth : Research Site:
Cambridge : Research Site:
Canterbury : Research Site:
Cardiff : Research Site:
Cottingham : Research Site:
Edinburgh : Research Site:
Glasgow : Research Site:
Hull : Research Site:
Leeds : Research Site:
Leicester : Research Site:
Liverpool : Research Site:
London : Research Site:
Sutton : Research Site:
Wakefield : Research Site:
Venezuela
Caracas : Research Site:
Leukemia Research Foundation | 3520 Lake Ave., Suite 202 | Wilmette, IL 60091 | 847.424.0600 | 847.424.0606 (fax)
The mission of the Leukemia Research Foundation is to conquer leukemia, lymphoma, and myelodysplastic syndromes by funding research into their causes and cures and to enrich the life of those touched by these diseases.
If you have any problems or suggestions with our website please contact our webmaster. ©2008 Leukemia Research Foundation | site map | privacy policy